Orally administered TQ-A3334 to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics single and multiple ascending doses in healthy Chinese subjects

被引：0
|
作者：
Hu, Yue [1 ]
Zhang, Hong [1 ]
Wu, Min [1 ]
Huo, Dandan [2 ]
Chen, Hong [1 ]
Li, Xiaojiao [1 ]
Xu, Zhongnan [2 ]
Ding, Yanhua [1 ]
Niu, Junqi [3 ]
机构：
[1] Jilin Univ, Phase Clin Res Ctr 1, Hosp 1, Changchun, Jilin, Peoples R China
[2] Chiatai Tianqing Pharmaceut Co Ltd, Changchun, Jilin, Peoples R China
[3] Jilin Univ, Hosp 1, Changchun, Jilin, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)30921-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-176
引用
收藏
页码：E466 / E467
页数：2
相关论文
共 50 条
  • [31] Safety, tolerability, pharmacokinetics, pharmacodynamics, bioavailability and food effect of single doses of soticlestat in healthy subjects
    Wang, Shining
    Chen, Grace
    Merlo Pich, Emilio
    Affinito, John
    Cwik, Michael
    Faessel, Helene
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (11) : 4354 - 4365
  • [32] Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults
    Courtney, R
    Pai, S
    Laughlin, M
    Lim, J
    Batra, V
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (09) : 2788 - 2795
  • [33] Pharmacokinetics, Safety, and Tolerability of Single-Dose Orally Administered Venglustat in Healthy Chinese Volunteers
    Yingxin Li
    Yang Li
    Li Li
    Wei Xue
    Kong Xin
    Titi Wang
    Aixin Shi
    Clinical Drug Investigation, 2023, 43 (6) : 413 - 420
  • [34] Pharmacokinetics, Safety, and Tolerability of Single-Dose Orally Administered Venglustat in Healthy Chinese Volunteers
    Li, Yingxin
    Li, Yang
    Li, Li
    Xue, Wei
    Xin, Kong
    Wang, Titi
    Shi, Aixin
    CLINICAL DRUG INVESTIGATION, 2023, 43 (06) : 413 - 420
  • [35] Safety, tolerability, pharmacokinetics and pharmacodynamics of dexlansoprazole injection in healthy Chinese subjects
    Yue-Qi Li
    Zheng-Yu Yan
    Hong-Wen Zhang
    Lu-Ning Sun
    Hui-Wen Jiao
    Mei-Feng Wang
    Li-Yuan Yu
    Lei Yu
    Zi-Qing-Yun Yuan
    Ling Meng
    Yong-Qing Wang
    European Journal of Clinical Pharmacology, 2017, 73 : 547 - 554
  • [36] Safety, tolerability, pharmacokinetics and pharmacodynamics of dexlansoprazole injection in healthy Chinese subjects
    Li, Yue-Qi
    Yan, Zheng-Yu
    Zhang, Hong-Wen
    Sun, Lu-Ning
    Jiao, Hui-Wen
    Wang, Mei-Feng
    Yu, Li-Yuan
    Yu, Lei
    Yuan, Zi-Qing-Yun
    Meng, Ling
    Wang, Yong-Qing
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (05) : 547 - 554
  • [37] Pharmacokinetics, pharmacodynamics and tolerability of the glucokinase activator AZD1656, after single ascending doses in healthy subjects
    Leonsson-Zachrisson, M.
    Norjavaara, E.
    Wollbratt, M.
    Persson, M.
    Alstrom, A. -M.
    Ueda, S.
    Roshammar, D.
    Ericsson, H.
    DIABETOLOGIA, 2011, 54 : S361 - S361
  • [38] A study to evaluate the safety, tolerability, and pharmacokinetics of multiple weekly doses of intravenous dalbavancin in healthy subjects
    Dunne, Michael W.
    Sprenger, Craig
    Moriarty, Susan
    PHARMACOTHERAPY, 2013, 33 (10): : E261 - E261
  • [39] Safety, pharmacokinetics (PK), and pharmacodynamics (PD) of ascending multiple doses of SRA-333 in healthy subjects
    Raje, SV
    Plotka, A
    Parks, V
    Patat, A
    Chassard, D
    NEUROBIOLOGY OF AGING, 2004, 25 : S215 - S215
  • [40] Pharmacokinetics and pharmacodynamics of intravenous ilaprazole in healthy subjects after single ascending doses
    Wang, Hongyun
    Ou, Ning
    Lang, Liwei
    Shi, Ruihua
    Hu, Pei
    Jiang, Ji
    XENOBIOTICA, 2016, 46 (12) : 1133 - 1141
12345